Neuromuscular
Clinical Research
If you think you may qualify for one of these studies, please contact Neurology Research Partners at (303) 724-4644 or NeurologyResearchPartners@CUAnschutz.edu
| COMIRB # | Title (Please click on the title to see approved advertisement) | Principal Investigator | Eligibility and Information | Advertisement |
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | ||||
| 19-1560 | Radicava/Edaravone Findings in Biomarkers From ALS (REFINE-ALS) | Laura Foster, MD | Clinical Trials | N/A |
| 19-2645 | Healey ALS Platform Trial | Laura Foster, MD | Clinical Trials | Platform Video |
| Chronic Inflammatory Demyelinating Polyneuropathy | ||||
| 19-1455 | Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP | Matthew Wicklund, MD | Clinical Trials | N/A |
Charcot Marie Tooth Disease | ||||
| 18-2537 | Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others (INC-6601) | Vera Fridman, MD | Clinical Trials | N/A |
| 20-1525 | Genetics of CMT – Modifiers of CMT1A, New Causes of CMT (INC-6602) | Vera Fridman, MD | Clinical Trials | N/A |
Facioscapulohumeral Muscular Dystrophy | ||||
| 20-0405 | Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD) | Matthew Wicklund, MD | Clinical Trials | N/A |
| Inclusion Body Myositis | ||||
| 17-1132 | Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis (IBM) – The International IBM Consortium Genetic Study | Matthew Wicklund, MD | Clinical Trials | N/A |
| Limb Girdle Muscular Dystrophy | ||||
| 19-2943 | Biomarker Development in LGMD 2i (MLB-01-001) | Matthew Wicklund, MD | Clinical Trials | N/A |
| 19-0506 | Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) (GRASP) | Matthew Wicklund, MD | Clinical Trials | N/A |
| Myasthenia Gravis | ||||
| 19-1597 | A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients with Generalized Myasthenia Gravis | Stacy Dixon, MD, PhD | Clinical Trials | N/A |
| 20-0609 | A Study of TAK-079 in People with Generalized Myasthenia Gravis | Thomas Ragole, MD | Clinical Trials | N/A |
| 20-1787 | Myasthenia Gravis Inebilizumab Trial (MINT) | Dianna Quan, MD | Clinical Trials | N/A |
| TTR Amyloidosis | ||||
| 08-0623 | Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS): A Global, Multi-Center, Longitudinal, Observational Survey of Patients with Documented Transthyretin (TTR) Mutations or Wild-Type TTR Amyloidosis | Dianna Quan, MD | Clinical Trials | N/A |
| 19-2873 | NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy | Dianna Quan, MD | Clinical Trials | N/A |